Skip to content

Antibiotic therapy for premature rupture of membranes and maternal outcomes in sayyad shirazi hospital-Gorgan

Antibiotic therapy for premature rupture of membranes and maternal outcomes in sayyad shirazi hospital-Gorgan

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017060228381N1
Enrollment
140
Registered
2017-06-02
Start date
2016-04-08
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature rupture of membranes. Premature rupture of membranes

Interventions

Intervention 1: The intervention group treated with amoxicillin 500 every 8 hours a week. Intervention 2: The control group without treatment oral antibiotics and monitored.
Treatment - Drugs
The intervention group treated with amoxicillin 500 every 8 hours a week
The control group without treatment oral antibiotics and monitored

Sponsors

*Golestan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 41 Years

Inclusion criteria

Inclusion criteria: Conditions of entry: Pregnant women with complaints of irritation between 34-24 weeks of pregnancy after ensuring rupture of membranes-by examination and testing Nitrazine; Exclusion criteria:Positive rectovaginal culture. Sample size: 140; divided into two groups of 70 pregnant woman.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Gestational age. Timepoint: admition date with PPROM. Method of measurement: According to the first FHR sonography.

Secondary

MeasureTime frame
Gestational age. Timepoint: delivery time. Method of measurement: According to the first FHR sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Zanbagh Pirastehfar

*Golestan University of Medical Sciences

pirastehfar@goums.ac.ir+98 11 3324 2474

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026